\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesCINEA and the European Commission's DG Climate Action and Research and Innovation are organising a virtual workshop on Innovation Fund synergies.
The focus of the workshop is to gather participants from mature R&I projects funded under EU R&I funding programmes (notably Horizon 2020) to explore funding opportunities under the EU Innovation Fund to deploy their technologies.
You can apply to present your project, or you can simply follow the event online. More information can be found on the event webpage. You can register here.
Preliminary agenda:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.